DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector, ranging from early stage companies to private equity. Our mission is to invest in and provide strategic value to the best companies and founding teams in healthcare. Our team is multidisciplinary, deeply rooted in healthcare and passionate about finding and helping the best companies to thrive. DNA Capital was founded in 2013 and is fully backed by the Bueno family. The Bueno family founded AMIL, Brazil’s largest health insurer, as well as numerous other leading healthcare companies. We invest globally from our offices located in São Paulo, Brazil and San Francisco, California.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Rua Joaquim Floriano 72, 20 Andar,brazil
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- dnacapital.com.br
- HQ
- São Paulo, SP
Dna Capital Questions
Dna Capital's website is dnacapital.com.br
Dna Capital's LinkedIn profile is https://br.linkedin.com/company/dna-capital-br
Dna Capital has
15 employees.
View email and phone details for 15
employees at Dna Capital.
Dna Capital's industry is
Venture Capital and Private Equity Principals
Dna Capital's top competitors are
Nice Healthcare,
Dgf,
Beep Saúde,
Dasa,
Dna Capital,
Dna Capital,
Dna Capital,
Lazuli Partners,
Kaszek,
Memed.
Dna Capital's categories are Venture Capital and Private Equity Principals
Dna Capital's founding year is 2013
